Updated CKD Guidelines Promote Cystatin C, Risk Equations, and SGLT2 Inhibitors

(MedPage Today) — Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization’s updated clinical practice guideline.
In a synopsis of the recently published guideline — serving…

Source link : https://www.medpagetoday.com/nephrology/generalnephrology/114580

Author :

Publish date : 2025-03-10 21:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

Updated CKD Guidelines Promote Cystatin C, Risk Equations, and SGLT2 Inhibitors

TYK2 Inhibitor Scores Two Wins Outside Plaque Psoriasis

Major ship collision in UK waters sparks fears of toxic chemical leak

Related Posts

High-Dose Vitamin D Reduces Disease Activity in Early Multiple Sclerosis

COVID Trial Networks Pivot to Studying Flu

What Did We Learn From the Earliest COVID Trials?

Major ship collision in UK waters sparks fears of toxic chemical leak

Largest all-electric flying machine begins sea trials

TYK2 Inhibitor Scores Two Wins Outside Plaque Psoriasis

High-Dose Vitamin D Reduces Disease Activity in Early Multiple Sclerosis

COVID Trial Networks Pivot to Studying Flu

What Did We Learn From the Earliest COVID Trials?

Major ship collision in UK waters sparks fears of toxic chemical leak

Updated CKD Guidelines Promote Cystatin C, Risk Equations, and SGLT2 Inhibitors

Largest all-electric flying machine begins sea trials

TYK2 Inhibitor Scores Two Wins Outside Plaque Psoriasis

Early Parenting Advice Lowers Kids’ Later BMI

Categories

Archives